TradingView
RocketTickers
15 paź 2019 16:15
Akorn Receives FDA Approval for Betamethasone Dipropionate Loti
Long
NASDAQ:AKRX
Opis
⋅
15 paź 2019 16:15
AKRX: Akorn, Inc.
2019-10-14 16:25:00
Akorn Receives FDA Approval for Betamethasone Dipropionate Lotion USP (Augmented), 0.05%
Beyond Technical Analysis
Więcej